A260660 Stock Overview
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Korea Arlico Pharm Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,080.00 |
| 52 Week High | ₩7,480.00 |
| 52 Week Low | ₩4,965.00 |
| Beta | 0.91 |
| 1 Month Change | -5.75% |
| 3 Month Change | -7.97% |
| 1 Year Change | -23.38% |
| 3 Year Change | -37.28% |
| 5 Year Change | -34.15% |
| Change since IPO | -65.95% |
Recent News & Updates
Recent updates
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?
Mar 24
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?
Mar 02Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares
Feb 12
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?
Jan 25Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?
Jan 04Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?
Dec 16Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?
Nov 25Shareholder Returns
| A260660 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.6% | 2.5% | 2.2% |
| 1Y | -23.4% | 6.7% | 5.4% |
Return vs Industry: A260660 underperformed the KR Pharmaceuticals industry which returned 6.7% over the past year.
Return vs Market: A260660 underperformed the KR Market which returned 5.4% over the past year.
Price Volatility
| A260660 volatility | |
|---|---|
| A260660 Average Weekly Movement | 2.4% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A260660 has not had significant price volatility in the past 3 months.
Volatility Over Time: A260660's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | n/a | www.arlico.co.kr |
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients.
Korea Arlico Pharm Co.,Ltd. Fundamentals Summary
| A260660 fundamental statistics | |
|---|---|
| Market cap | ₩77.86b |
| Earnings (TTM) | ₩3.06b |
| Revenue (TTM) | ₩187.15b |
25.4x
P/E Ratio0.4x
P/S RatioIs A260660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A260660 income statement (TTM) | |
|---|---|
| Revenue | ₩187.15b |
| Cost of Revenue | ₩77.04b |
| Gross Profit | ₩110.12b |
| Other Expenses | ₩107.06b |
| Earnings | ₩3.06b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 199.71 |
| Gross Margin | 58.84% |
| Net Profit Margin | 1.64% |
| Debt/Equity Ratio | 51.7% |
How did A260660 perform over the long term?
See historical performance and comparison